Mark J. Levin, 10% Owner at Blueprint Medicines Corp (BPMC), sold 35,200 shares at $41.55 ($1.4M) on 2017-03-16, disclosed to the SEC on 2017-03-20.
Open-market sale of $1.4M BPMC by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.74 | 24,800 | $1.0M | 70.0% |
| 2 | $41.55 | 5,200 | $216K | 15.0% |
| 3 | $41.55 | 5,200 | $216K | 15.0% |
| Total | $40.98 avg | 35,200 | $1.4M | 100% |
| Filing → |
| MLNM | SELL | 2008-01-10 | $29K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $42K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $120K | — | Filing → |